NextMeds review

Take a quarter dose here and you pay what a full dose costs. NextMeds states the basis in its own words — "Same price, every dose" — and confirms that the monthly fee covers the medication itself rather than just access, which is worth knowing, because plenty of cheap-looking memberships bill the drug separately. It also names its prescribing clinicians and their NPI numbers, which is rare and independently checkable, and it names its operating entity separately from the medical practice. Three things will cost you. The figures in the banner are the twelve-month prepay rates; month to month costs meaningfully more on both molecules. The hero promising the same price every month sits directly above a countdown headed "Price increases in", and the deadline the banner names is not the day that clock runs out. And no milligram figure is published against any price, so there is no range to bound the flat claim.

Vs median

$90/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

NextMeds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

NextMeds sells compounded semaglutide and compounded tirzepatide as a flat monthly membership covering "medical oversight, medication and 24/7 support", offered month to month or on three-, six- and twelve-month terms. It states its dose basis directly — "Same price, every dose, No hidden fees" — and names the clinicians behind the prescriptions with their NPI numbers: Dr. Ana Lisa Carr MD (1689841744) and Dr. Kelly Tenbrink MD (1346482684), of OpenLoop Healthcare Partners, PC. It is one of FOUR brands run by Trinity HealthCare Supply, LLC, and one of the others sells the same tirzepatide for less. No compounding pharmacy is named.

ONE PRICE AT EVERY DOSE, stated outright. A patient deliberately holding at a quarter dose pays exactly what a full-dose patient pays, and no low-dose product is published to move to instead

• The banner's "$69 | $99" figures are the twelve-month prepay rates. The month-to-month rates are $79 and $119
• The hero reads "Same price every month — first order and every order after" directly above a countdown headed "Price increases in", and the banner's "OFFER ENDS AUGUST 15TH AT MIDNIGHT" disagrees with that countdown, which read 4 days 4 hours on 2026-08-10 and lands on August 14
• The same product costs less at a sister brand: four brands here are all Trinity HealthCare Supply, LLC, and tirzepatide is $119/month here against $109/month at one of them
• No milligram quantity is published against any price, so the flat-dose claim has no published range to bound it
• No compounding pharmacy is named — only "the NextMeds pharmacy network" — while its sister brand names four
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

NextMeds is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan